Cell and Gene Therapy Catapult

The Cell and Gene Therapy Catapult is a pioneering organisation based in the UK, dedicated to advancing the field of cell and gene therapies. Established to support the growth of this innovative sector, the Catapult plays a crucial role in bridging the gap between research and commercialisation.

With a focus on enhancing the UK’s position as a global leader in cell and gene therapy, the Catapult provides a range of services designed to accelerate the development of new therapies. These services include:

• Technical Expertise: Offering guidance on manufacturing processes, regulatory compliance, and quality assurance.
• Research Collaboration: Facilitating partnerships between academia and industry to foster innovation.
• Funding Support: Assisting companies in securing funding for their projects through various initiatives.
• Training and Development: Providing training programmes to develop the skills necessary for the workforce of the future.

The Catapult is committed to ensuring that the UK remains at the forefront of cell and gene therapy advancements. By fostering a collaborative environment, it aims to bring together stakeholders from various sectors, including biotechnology, pharmaceuticals, and healthcare.

Through its efforts, the Cell and Gene Therapy Catapult not only supports the development of groundbreaking therapies but also contributes to improving patient outcomes and transforming lives. The organisation’s vision is to create a sustainable ecosystem that nurtures innovation and drives the successful delivery of cell and gene therapies to patients worldwide.